2026-06-03
2 小时 15 分钟In genetic medicine, I would call it the holy grail for the last 30 years has been thinking
about how do we administer intravenous,
which means into the bloodstream, genetic medicines that can get to places throughout the body.
We've been trapped in one organ for the past 30 years, and that's the liver.
We are the first company that I'm aware of to show this extent of abscopal response in visceral,
deep organ metastases in a multitude of patients.
And really right off the bat, what I want the world to understand
is that we are standing right now on the precipice of a revolution in genetic medicine.
We're going to be able to get to a point in the not-too-distant future
where I think a lot of types of cancers are, at the very least, chronic diseases instead of death sentences.
Hello, boys and girls, ladies and germs.
This is Tim Ferriss.
Welcome to another episode of The Tim Ferriss Show, where it's my job to deconstruct world-class performers.
Has been my job for more than a decade.
This episode's gonna be an experimental format.
It's gonna be half interview, half live jam session,
because many of the most fascinating conversations that I have, I cannot record.
They're often involving startup founders because for close to 20 years I've been an angel investor
that started in 2008 in the Bay Area, and some of those companies include Shopify;
I was the first advisor when they had something like 10 or 12 employees, Uber: